Mostrar el registro sencillo del ítem
Virus del papiloma humano y cáncer de cuello uterino ¿vacunar o no vacunar?
| dc.contributor.author | Serrano-Gómez, Sergio Eduardo | spa |
| dc.date.accessioned | 2020-10-27T14:19:52Z | |
| dc.date.available | 2020-10-27T14:19:52Z | |
| dc.date.issued | 2015-08-12 | |
| dc.identifier.issn | 2382-4603 | |
| dc.identifier.issn | 0123-7047 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12749/10081 | |
| dc.description.abstract | En los últimos meses ha circulado por múltiples medios de comunicación: noticieros, periódicos e internet un creciente movimiento en contra de la vacunación contra el virus del papiloma humano (VPH), alegando que la vacuna es poco efectiva, genera infertilidad y presenta eventos adversos fatales, lo cual ha producido un pánico masivo, que ha llevado a que muchos padres duden sobre si permitir o no la vacunación de sus hijas. Considero que para responder esta pregunta con seriedad es necesario realizar una revisión de la evidencia actual del tema en general, incluidos los beneficios y riesgos de la vacuna. | spa |
| dc.format.mimetype | application/pdf | spa |
| dc.language.iso | spa | spa |
| dc.publisher | Universidad Autónoma de Bucaramanga UNAB | |
| dc.relation | https://revistas.unab.edu.co/index.php/medunab/article/view/2515/2148 | |
| dc.relation.uri | https://revistas.unab.edu.co/index.php/medunab/article/view/2515 | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | |
| dc.source | MedUNAB; Vol. 18 Núm. 2 (2015): Agosto - Noviembre de 2015: Indicadores de carga del cuidado, Dengue, Cervicitis Uterina.; 103-104 | |
| dc.title | Virus del papiloma humano y cáncer de cuello uterino ¿vacunar o no vacunar? | spa |
| dc.title.translated | Human papilloma virus and cervical cancer. vaccinate or not? | eng |
| dc.publisher.faculty | Facultad Ciencias de la Salud | spa |
| dc.publisher.program | Pregrado Medicina | spa |
| dc.type.driver | info:eu-repo/semantics/article | |
| dc.type.local | Artículo | spa |
| dc.type.coar | http://purl.org/coar/resource_type/c_6501 | |
| dc.subject.keywords | Viruses | eng |
| dc.subject.keywords | Uterine cervical neoplasms | eng |
| dc.subject.keywords | Vaccination | eng |
| dc.identifier.instname | instname:Universidad Autónoma de Bucaramanga UNAB | spa |
| dc.type.hasversion | Info:eu-repo/semantics/publishedVersion | |
| dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | spa |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.relation.references | CuttsF,FranceschiS.HumanpapillomavirusandHPVvaccines: a review. Bull World [revista en internet]. 2007 [Acceso2014May2];038414(September):719–26. Disponible:http://www.scielosp.org/scielo.php?pid=S0042-96862007000900018&script=sci_arttext | spa |
| dc.relation.references | Schiller JT, Lowy DR. Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat Rev Microbiol [revista en internet]. 2012 Oct [Acceso 2012 Nov18];10(10):681–92.Disponible:http://www. ncbi.nlm.nih.gov/pubmed/22961341 | spa |
| dc.relation.references | International Agency for Research on Cancer.World Health Organization.GLOBOCAN2008.CancerIncidenceand Mortality Worldwide in 2008 [revista en internet]. 2008 [Acceso 2012 Oct 15]. Disponible: http://globocan.iarc.fr | spa |
| dc.relation.references | HerreroR,WacholderS,RodríguezAC,SolomonD, González P, Kreimer AR, et al. Prevention of persistent human papillomavirusinfectionbyanHPV16/18vaccine:a community-based randomized clinical trial in Guanacaste, Costa Rica. Cancer Discov [revista en internet]. 2011 Oct [Acceso2012Oct14];1(5):408–19.Disponible: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3354733&tool=pmcentrez&rendertype=abstract | spa |
| dc.relation.references | Muñoz N, Kjaer SK, Sigurdsson K, Iversen O-E, Hernandez-Avila M, Wheeler CM, et al. Impact of human papillomavirus (HPV)-6/11/16/18vaccineonallHPV-associatedgenital diseases in young women. J Natl Cancer Inst [revista en internet]. 2010 Mar 3 [Acceso 2012 Oct 14];102(5):325–39. Disponible: http://www.ncbi.nlm.nih.gov/pubmed/20139221 | spa |
| dc.relation.references | CastellsaguéX,MuñozN,PitisuttithumP,FerrisD, MonsonegoJ,AultK,etal.End-of-studysafety, immunogenicity, and efficacy of quadrivalent HPV(types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer [revista en internet]. 2011 Jun 28 [Acceso 2012Oct15];105(1):28–37.Disponible: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3137403&tool=pmcentrez&rendertype=abstract | spa |
| dc.relation.references | Roteli-Martins CM, Naud P, De Borba P, Teixeira JC, De Carvalho NS, Zahaf T, et al. Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 yearsoffollow-up.HumVaccinImmunother[revistaen internet]. 2012 Mar 1 [Acceso 2012 Nov 14];8(3):390–7. Disponible: http://www.ncbi.nlm.nih.gov/pubmed/22327492 | spa |
| dc.relation.references | Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPVinfection and diseases among women: a systematic review & meta-analysis. BMCInfect Dis [revista en internet]. 2011 Jan [Acceso2014May2];11:13.Disponible: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid =3034689&tool=pmcentrez&rendertype=abstract | spa |
| dc.relation.references | Crawford NW, Clothier HJ, Elia S, Lazzaro T, Royle J, Buttery JP. Syncope and seizures following human papillomavirus vaccination: a retrospective case series. Med J Aust [revista en internet]. 2011 Jan 3 [Acceso 2014 May 2];194(1):16–8. Disponible: http://www.ncbi.nlm.nih.gov/pubmed/21449862 | spa |
| dc.relation.references | Rodríguez-Galán MA, Pérez-Vilar S, Díez-Domingo J, Tuells J, Gomar-Fayos J, Morales-Olivas F, et al. [Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007-2011).]. An Pediatr (Barc) [revista en internet]. 2014 Feb 26[Acceso2014May2];Disponible:http://www. ncbi.nlm.nih.gov/pubmed/24582127 | spa |
| dc.relation.references | Diaz R. De las probabilidades de morir en un accidente de tránsito [revista en internet]. Pedestre. 2009. Disponible: http://ciudadpedestre.wordpress.com/2009/05/14/de-las-probabilidades-de-morir-en-un-accidente-de-transito/ | spa |
| dc.contributor.cvlac | Serrano-Gómez, Sergio Eduardo [0001521095] | spa |
| dc.contributor.googlescholar | Serrano-Gómez, Sergio Eduardo [e0iMQ5oAAAAJ&hl=es&oi=ao] | spa |
| dc.contributor.orcid | Serrano-Gómez, Sergio Eduardo [0000-0001-6418-7116] | spa |
| dc.contributor.scopus | Serrano-Gómez, Sergio Eduardo [57197758865] | spa |
| dc.subject.lemb | Ciencias de la salud | spa |
| dc.subject.lemb | Medicina | spa |
| dc.subject.lemb | Ciencias medicas | spa |
| dc.identifier.repourl | repourl:https://repository.unab.edu.co | |
| dc.description.abstractenglish | In recent months there has circulated through multiple media: news, newspapers and the Internet is a growing movement against vaccination against human papillomavirus (HPV), claiming that the vaccine is ineffective, generates infertility and presents fatal adverse events , which has produced a massive panic that has led many parents hesitate about whether to allow vaccination of their daughters. I believe that to answer this question seriously need a review of the current evidence of the subject in general, including the benefits and risks of the vaccine. | eng |
| dc.subject.proposal | Vacunación | spa |
| dc.subject.proposal | Neoplasias del cuello uterino | spa |
| dc.subject.proposal | Virus | spa |
| dc.identifier.doi | 10.29375/01237047.2515 | |
| dc.type.redcol | http://purl.org/redcol/resource_type/ART | |
| dc.contributor.researchgroup | Grupo de Investigaciones Clínicas | spa |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Grupo de Investigaciones Clínicas [1672]
-
Revista MedUNAB [817]
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by-nc-nd/2.5/co/